Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma

NCT06759155 is registered in ClinicalTrials.gov with University of Vermont Medical Center as lead sponsor.

NCT NCT06759155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06759155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma
Lead sponsor
University of Vermont Medical Center
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
January 31, 2030
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hpv associated cancers, opscc, oropharyngeal squamous cell carcinoma (scc)